Selway Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Selway Asset Management's GILD Position: Q1 2020 in Review
Selway Asset Management sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 9,100 shares — an estimated $591K sold.
Selway Asset Management first reported a position in GILD in Q2 2014 and held it in 23 quarters. The position peaked at $6.3M in Q3 2014. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.
- Selway Asset Management reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
- Selway Asset Management sold 9,100 Gilead Sciences shares in Q1 2020, an estimated $591K.
- Selway Asset Management first reported a position in Gilead Sciences in Q2 2014 and held it in 23 quarters.
- Selway Asset Management's Gilead Sciences position peaked at $6.3M in Q3 2014.
- 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.
Based on Selway Asset Management's 13F filing for Q1 2020, filed 22 Apr 2020.